Glycolate 1 Tablet contains Glycopyrrolate 1 mg, an anticholinergic agent primarily used to reduce excessive secretions in the respiratory and gastrointestinal tracts. Glycopyrrolate acts by competitively inhibiting the action of acetylcholine on muscarinic receptors, thereby decreasing salivary, bronchial, and gastric secretions. It is commonly prescribed for patients undergoing surgery to minimize oral and respiratory secretions, as well as for managing peptic ulcers and certain cases of hyperhidrosis. Additionally, Glycopyrrolate is utilized in the treatment of chronic obstructive pulmonary disease (COPD) to aid bronchodilation and reduce mucus production. The drug’s quaternary ammonium structure limits its penetration into the central nervous system, resulting in fewer central side effects compared to other anticholinergics. Glycolate 1 Tablet should be administered as directed by a healthcare professional, with dosage adjustments based on the clinical condition and patient response. Common adverse effects may include dry mouth, blurred vision, urinary retention, constipation, and tachycardia. Caution is advised in patients with glaucoma, prostatic hypertrophy, or cardiac conditions. Glycolate 1 Tablet is contraindicated in individuals with hypersensitivity to glycopyrrolate or other anticholinergic agents. Regular monitoring and adherence to prescribed dosage ensure optimal therapeutic outcomes.